Results 21 to 30 of about 12,413,959 (307)

Perioperative replacement therapy in haemophilia B: An appeal to “B” more precise [PDF]

open access: hybridHaemophilia, 2018
Haemophilia B is caused by a deficiency of coagulation factor IX (FIX) and characterized by bleeding in muscles and joints. In the perioperative setting, patients are treated with FIX replacement therapy to secure haemostasis.
H. Hazendonk   +14 more
semanticscholar   +2 more sources

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX. [PDF]

open access: goldJ Clin Med
Park YS   +16 more
europepmc   +3 more sources

Haemophilia B is clinically less severe than haemophilia A: further evidence. [PDF]

open access: yesBlood Transfus, 2018
Preview Haemophilia A and B are rare bleeding disorders caused by mutations in the genes encoding coagulation factor VIII (FVIII) and factor IX (FIX)1. The prevalence of haemophilia A is 1 in 5,000 males in the general population, while that of haemophilia B is 1 in 40,0001,2.
Franchini M, Mannucci PM.
europepmc   +3 more sources

Promoterless gene targeting without nucleases ameliorates haemophilia B in mice

open access: greenNature, 2014
Adi Barzel   +10 more
exaly   +2 more sources

Prophylaxis use among males with haemophilia B in the United States. [PDF]

open access: yesHaemophilia, 2017
Ullman M   +5 more
europepmc   +2 more sources

Impact of Functional Disability on Quality of Life in Patients with Haemophilia: An Observational Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Introduction: Haemophilia is a disease characterised by multiple episodes of spontaneous as well as traumatic bleeding leading to joint pains, joint damage.
Ashish Kavi   +3 more
doaj   +1 more source

Gene Therapy in Hemophilia: A Transformational Patient Experience

open access: yesJournal of Patient Experience, 2023
Hemophilia is a bleeding disorder caused by a single absent/defective gene and characterized by a lack of functional clotting factors. People with hemophilia may experience joint damage, pain, and psychological impairments, all of which could contribute ...
Enayet Rasul   +7 more
doaj   +1 more source

The B-team: Equal but different?

open access: yesThe Journal of Haemophilia Practice, 2021
As a person with haemophilia B, I have known there are differences between haemophilia A and haemophilia B and their respective treatment throughout my life – though I was shocked when I learnt about the impact inhibitors can have when it comes to ...
Pembroke Luke
doaj   +1 more source

The profile of patients with haemophilia managed at a haemophilia treatment centre in Pretoria, Gauteng

open access: yesSouth African Family Practice, 2022
Background: Haemophilia A and B are X-linked recessive bleeding disorders resulting from a deficiency of factors VIII and IX, respectively. Early diagnosis and a comprehensive approach to management is mandatory.
Lethukuthula Mafisa   +2 more
doaj   +1 more source

Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors

open access: yesHaemophilia, 2022
Haemophilia B patients with factor IX inhibitors have particularly unmet needs for conventional therapy.
M. Sakai   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy